Mats Hidestrand
- Pharmacology top 0.2%
- Molecular Biology
- Oncology top 10%
- Pediatrics, Perinatology and Child Health top 5%
- Pharmacology top 5%
- Co-authors
- Magnus Ingelman‐SundbergMikael OscarsonGunnel TybringInger JohanssonPippa SimpsonErik EliassonÜmit YaşarBrith Leidvik
- Topics
- Pharmacogenetics and Drug Metabolism (20 papers)Renal Transplantation Outcomes and Treatments (7 papers)Drug Transport and Resistance Mechanisms (7 papers)
- Partner nations
- United StatesSwedenItaly
In The Last Decade
Mats Hidestrand
40 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 97
- Pharmacology 876
- Molecular Biology 549
- Oncology 439
- Pediatrics, Perinatology and Child Health 229
- Pharmacology 183
Countries citing papers authored by Mats Hidestrand
This map shows the geographic impact of Mats Hidestrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Hidestrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Hidestrand more than expected).
Fields of papers citing papers by Mats Hidestrand
This network shows the impact of papers produced by Mats Hidestrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Hidestrand. The network helps show where Mats Hidestrand may publish in the future.
Co-authorship network of co-authors of Mats Hidestrand
This figure shows the co-authorship network connecting the top 25 collaborators of Mats Hidestrand. A scholar is included among the top collaborators of Mats Hidestrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mats Hidestrand. Mats Hidestrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 62 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 57 | |
| 6 | 15 | |
| 7 | 37 | |
| 8 | 53 | |
| 9 | 16 | |
| 10 | 47 | |
| 11 | 30 | |
| 12 | 28 | |
| 13 | 13 | |
| 14 | 61 | |
| 15 | 55 | |
| 16 | 110 | |
| 17 | 49 | |
| 18 | 102 | |
| 19 | 75 | |
| 20 | 46 |
About Mats Hidestrand
Mats Hidestrand is a scholar working on Transplantation, Pharmacology and Biochemistry, having authored 40 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (20 papers), Renal Transplantation Outcomes and Treatments (7 papers) and Drug Transport and Resistance Mechanisms (7 papers). The work is most often cited by research in Pharmacology (876 citations), Transplantation (90 citations) and Biochemistry (144 citations). Mats Hidestrand has collaborated with scholars based in United States, Sweden and Italy. Frequent co-authors include Magnus Ingelman‐Sundberg, Mikael Oscarson, Gunnel Tybring, Inger Johansson, Pippa Simpson, Erik Eliasson, Ümit Yaşar, Brith Leidvik, Christer von Bahr and Thomas M. Badger. Their work appears in journals such as Journal of Biological Chemistry, Journal of the American College of Cardiology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.